Background: Sonic hedgehog (Shh) and components of its signalling pathway have been identified in human prostate carcinoma and increased levels of their expression appear to correlate with disease progression and metastasis. The mechanism through which Shh signalling could promote metastasis in bone, the most common site for prostate carcinoma metastasis, has not yet been investigated. The present study determined the effect of Shh signalling between prostate cancer cells and pre-osteoblasts on osteoblast differentiation, a requisite process for new bone formation that characterizes prostate carcinoma metastasis.
Background
Bone is the most common site for metastasis of prostate carcinoma affecting as many as 90% of patients with metastatic disease [1] . Complications from skeletal metastasis result in a dramatic reduction in the patient's quality of life and invariably lead to death [2, 3] . A clear understanding of the factors and mechanisms that promote the migration of prostate cancer cells to bone, their colonization of the bone environment and subsequent formation of metastases is critically needed to prevent and effectively treat this disease. The commonly held "seed and soil" theory emphasizes the importance of the bone microenvironment in determining the colonization success of neoplastic "seed" cells [4] . On the other hand, prostate cancer cells can alter gene expression and cell functions in osteoblasts, suggesting that invading tumor cells might also influence the host bone milieu making it a favourable "soil" for metastasis [5, 6] . This latter view fuels the ongoing search for factors secreted by prostate cancer cells that might uniquely signal to bone and promote metastases.
Sonic hedgehog (Shh) is a secreted glycopeptide that plays essential functions in development and disease [7, 8] . The binding of Shh to its transmembrane receptor Patched 1 (Ptc1) triggers the release of the transmembrane protein Smoothened (Smo) from Ptc1-mediated inhibition. Subsequent activation of the intracellular signalling cascade leads to the transcriptional regulation of Shh target genes by the Gli family of transcription factors: Gli1, Gli2, and Gli3.
Shh and members of its signalling pathway are expressed in prostate carcinoma and increased levels of their expression appear to correlate with cancer progression and metastasis [9] [10] [11] [12] . Shh expression has been localized in prostatic epithelia or glandular lumens of prostate tumors indicating that epithelial-derived prostate cancer cells are a primary if not sole source of the Shh protein [9, 11] .
We have shown previously that Shh-expressing human prostate cancer cells upregulated Gli1 expression in surrounding tumor stroma and accelerated tumor growth in a mouse xenograft model of human prostate cancer [9] . This apparent paracrine activation of the pathway in prostate tumorigenesis is highly reminiscent of Shh-Gli signalling at epithelial-mesenchymal boundaries in several developing organ systems including the prostate that promotes cell proliferation and morphogenesis [13, 14] .
The mechanism by which Shh-Gli signalling could promote prostate carcinoma metastasis in bone has not been previously determined. The present study provides evidence of direct and specific paracrine Shh-Gli signalling between prostate cancer cells and pre-osteoblasts which leads to osteoblast differentiation, a requisite process for osteoblastic metastasis.
Results
Shh-expressing human prostate cancer cells, LNShh, directly activate hedgehog signalling in MC3T3 preosteoblasts Paracrine interactions between cells have traditionally been studied in vitro by co-culturing cells in separate chambers while sharing the same culture medium. We have developed a non-conventional mixed culture system where different cell populations are cultured within the same chamber, thus, allowing them to establish physical associations that most likely occur in vivo and influence cell-cell signalling. To demonstrate activation of Shh signalling in pre-osteoblasts by Shh-expressing prostate cancer cells in mixed cultures, the expression of known Shh target genes Gli1 and Ptc1 were determined by quantitative real time RT-PCR analysis using species specific primer sequences (Table 1) which amplified these genes in mouse MC3T3 cells but not in the human prostate cancer cells. Thus, amplification of Gli1 and Ptc1 in mixed cultures is highly, if not solely, attributable to their expression in MC3T3 mouse pre-osteoblasts. Conversely, using primers that amplified genes in human but not mouse cells, we determined that expression of human GLI1 did not differ significantly between control LNCaP and LNShh cells cultured with MC3T3 cells suggesting the absence of significant autocrine or feedback paracrine regulation of the hedgehog pathway, at least under conditions used in these studies (data not shown). We have previously used species-specific primers in RT-PCR analysis to demonstrate the upregulation of mouse Gli1 in mouse xenografts of human prostate carcinoma [9] .
MC3T3 pre-osteoblasts in mixed cultures with LNShh cells expressed increased levels of Gli1 and Ptc1 compared to those cultured with control LNCaP cells (Figure 2A) . In a traditional co-culture system where cells were grown in separate chambers but shared the same culture medium, MC3T3 cells co-cultured with LNShh cells also expressed higher levels of Gli1 and Ptc1 ( Figure 2B ). Serum-free conditioned media from single confluent cultures of LNShh cells also increased Gli1 and Ptc1 expression in MC3T3 cells cultured alone which is consistent with the soluble nature of the secreted Shh ligand (data not shown). Figure 2C ). Activation of the hedgehog pathway in MC3T3 cells was a direct and immediate effect of Shh action since exogenous Shh peptide (Shh-N) increased Gli1 and Ptc1 message as early as 24 h following treatment ( Figure 2D ).
These data demonstrate specific and direct paracrine activation of Shh signalling in pre-osteoblasts by Shh-expressing prostate cancer cells. 
LNShh cells upregulate Gli1 and

LNShh cells induce early phase osteoblast differentiation
The ability of LNShh cells to induce osteoblast differentiation was examined. The initial phase of osteoblast differentiation is characterized by cell proliferation followed by growth arrest [15] . As shown in Figure 3A , proliferation of MC3T3 cells co-cultured with LNShh cells was significantly decreased by days 5 and 7 of co-culture compared to that of MC3T3 cells co-cultured with control LNCaP cells or cultured alone. These data suggest that Shhexpressing prostate cancer cells can inhibit cell proliferation in pre-osteoblasts.
Cell proliferation arrest is associated with a time-dependent increase in alkaline phosphatase (ALP) activity, a wellestablished indicator of osteoblast differentiation [15] . ALP activity in mixed cultures of MC3T3 and LNShh cells increased with time and was significantly higher relative to that in mixed cultures of MC3T3 and control LNCaP cells ( Figure 3B ). Staining for ALP activity was performed to determine the spatial localization of activity in mixed cultures. Consistent with data shown in Figure 3B , staining for ALP activity was greater in mixed cultures of LNShh and MC3T3 cells and intensified progressively through time ( Figure 3C ). Staining for ALP activity was localized almost exclusively in MC3T3 cells which surrounded clusters of LNShh cells ( Figure 3C ). 
Gli1 transcriptional activity is required for LNShh cellinduced osteoblast differentiation
To establish that LNShh cell-induced osteoblast differentiation occurred via the Shh signalling pathway, MC3T3 cells were stably transfected with human GLI1 cDNA which has a deletion in the region containing the trans activation domain: pCMV-GLI(-)TAD [16] . The translated GLI1 protein in transfected MC3T3 cells, designated as M-TAD cells, is expected to bind to the consensus DNA Gli
LNShh cells induce osteoblast differentiation 
LNShh cells do not upregulate the expression of Runx2
The transcription factor Runx2 plays a pivotal role in osteoblast differentiation and function [17, 18] . The effect of LNShh cells on Runx2 expression in MC3T3 cells in mixed cultures was determined. Endogenous levels of Runx2 were not significantly changed in MC3T3 cells cultured with LNShh cells ( Figure 5A , b relative to a). In addition, the expression of Runx2 target genes osteocalcin (Ocn) and osteopontin (Opn) were not significantly increased ( Figure 5A , c and d, respectively, relative to a).
Consistent with these data, activation of the Shh pathway in MC3T3 cells by exogenous Shh-N, as evidenced by increased expression in Gli1 and Ptc1, did not upregulate Runx2 expression ( Figure 5B ). On the other hand, exogenous AA significantly increased Runx2 levels in MC3T3 cells without activating the Shh pathway ( Figure 5B ). Combined stimulation with Shh-N and AA did not significantly increase the expression of Runx2 relative to treatment with AA alone, or the expression of Shh target genes Gli1 and Ptc1 relative to treatment with Shh-N alone indicating the absence of synergistic interaction between these two factors. AA upregulates the expression of osteoblast differentiation marker genes including Runx2 and promotes osteoblast differentiation [19, 20] . These data, therefore, indicate that early phase osteoblast differentia- tion in pre-osteoblasts induced by paracrine Shh signalling might proceed in a mechanism that does not require the transcriptional regulation of Runx2.
Discussion
The functional relevance of upregulated Shh expression in human prostate carcinoma to the development of bone metastasis has not been previously investigated. We now provide data which indicate that prostate cancer cells that express high levels of Shh can directly and specifically activate the signalling pathway in osteoblast progenitors and induce osteoblast differentiation, an essential process in new bone formation that characterizes prostate carcinoma metastasis.
LNCaP human prostate cancer cells genetically engineered to overexpress Shh (designated LNShh cells) upregulated the expression of Shh-responsive target genes Gli1 and Ptc1 in co-cultured MC3T3 mouse pre-osteoblasts and this action was inhibited by cyclopamine, a specific chemical inhibitor of hedgehog signalling, and mimicked by exogenous Shh peptide. LNShh cell-induced activation of the Shh signalling pathway in pre-osteoblasts led to the induction of early phase osteoblast differentiation characterized by abrogated cell proliferation and increased expression and activity of alkaline phosphatase. Conversely, failure to activate the Shh pathway by a dominant negative form of the transcription factor Gli1 in pre-osteoblasts inhibited LNShh cell-induced osteoblast differentiation. These data confirm previous findings which have demonstrated a role for the hedgehog proteins, Shh and Indian hedgehog (Ihh), in osteoblast differentiation [21] [22] [23] [24] [25] [26] [27] .
Ihh, Ptc1, Smo, Gli1, Gli2, and Gli3 are expressed in developing bone, and hedgehog signalling plays a vital role in skeletal development [28] [29] [30] [31] [32] [33] [34] [35] . The expression of Ptc1, Smo, and Gli1 in perichondrial cells adjacent to Ihhexpressing prehypertropic chondrocytes strongly suggests a paracrine pathway through which hedgehog signalling might induce differentiation of perichondrial cells into osteoblasts during endochondral bone formation [21, 30, 34, 35] .
Our data suggest that the apparent paracrine pathway of hedgehog signalling in bone development may be recapitulated in bone metastasis where Shh-expressing prostate cancer cells activate the pathway in osteoblast progenitors and induce osteoblast differentiation. Reciprocally, differentiated osteoblasts might provide factors that are favourable to tumor growth in bone. Many identified downstream target genes of Gli1 transcriptional activity are known to regulate cell proliferation and cell adhesion [36] .
The downstream mechanism through which Shh signalling induces osteoblast differentiation is not fully understood. Runx2 (also known as Cbfa1: core-binding factor 1) encodes a major and critical transcription activator of osteoblast differentiation [17, 37, 38] . A recent study has demonstrated that Ihh promotes osteoblast differentiation in multipotent mesenchymal cells C3H10T1/2 by upregulating the expression and function of Runx2 through the transcriptional action of Gli2 [27] . Our data, however, show that LNShh cell-induced early phase differentiation in MC3T3 pre-osteoblasts was not accompanied by a significant increase in endogenous levels of Runx2 and its downstream target genes Ocn and Opn. Moreover, exogenous Shh-N did not directly upregulate Runx2 expression in MC3T3 cells; whereas, the osteoblast differentiation factor AA increased Runx2 levels in MC3T3 cells without activating the Shh pathway. These data suggest that in cells that are already committed to the osteoblast lineage and express endogenous levels of Runx2, as is the case with MC3T3 cells, the induction of osteoblast differentiation by Shh signalling occurs through a mechanism that does not require further transcriptional upregulation of Runx2. Similarly, Xiao and co-workers concluded that osteoblast differentiation induced by bone morphogenetic protein (BMP) in mature osteoblast precursors does not require increased expression of Cbfa1 (Runx2) but might involve posttranscriptional regulation of the Runx2 protein [39] . In multipotent mesenchymal progenitors, however, Shh signalling promotes osteoblast commitment and differentiation through the upregulation of Runx2 message and activity [27, 40] .
Shh may act in concert with other factors in regulating osteoblast differentiation. Prostate cancer cells secrete signalling ligands including growth factors, bone morphogenetic proteins, and parathyroid hormone-related protein which are known to regulate osteoblast functions and whose actions have been linked to hedgehog signalling [5, 6, 24, 41, 42] . More studies are needed to tease out the functional interplay between hedgehog signalling and other pathways in the development of prostate carcinoma metastasis in bone.
Prostate cancer cells that metastasize to bone or those that are directly injected in bone in animal models will be in close physical contact with bone stromal cells including bone cells and their osteoblast progenitors, fibroblasts, hematopoetic cells, and multipotent mesenchymal stem cells. In the presence of mixed cell populations within the bone environment, it is difficult to isolate and determine direct cell-cell interactions that might impact the development of prostate carcinoma metastasis. The non-conventional mixed culture system developed in these studies provides an excellent in vitro model to investigate early outcomes of paracrine signalling between defined cell populations and to evaluate how these interactions might be impacted by other signalling pathways and/or therapeutic interventions.
Conclusion
This study presents evidence that Shh-expressing prostate cancer cells directly and specifically activate the Shh signalling pathway in pre-osteoblasts. Paracrine Shh signalling in pre-osteoblasts leads to osteoblast differentiation via a Gli1-dependent mechanism that does not require transcriptional upregulation of endogenous Runx2 expression. These data provide a mechanism through which increased levels of Shh in human prostate carcinoma might specifically promote bone metastasis.
Methods
Plasmid Transfections
LNCaP human prostate cancer cells (ATCC, Rockville, MD) have been previously stably transfected with a 1.44 kb human Shh cDNA cloned into a pIRES2-EGFP mammalian cell expression vector (designated as LNShh cells) or with pIRES2-EGFP vector alone [9] . LNShh and control LNCaP cells were maintained at 37C, 5% CO 2 in complete culture medium consisting of RPMI-1640 supplemented with 10% fetal bovine serum (FBS), 100 U/ml penicillin and 100 μg/ml streptomycin (Gibco Invitrogen). Shh gene and protein expression were routinely determined by quantitative real time RT-PCR and western blot analysis, respectively, and GFP expression was monitored by fluorescence microscopy.
Cells from the mouse calvaria-derived non-transformed pre-osteoblast cell line MC3T3-E1 (subclone 4; ATCC, Rockville, MD: designated as MC3T3 cells), were transfected with pCMV-GLI(-)TAD: a human GLI1 cDNA lacking a trans activation domain and cloned into pcDNA3 plasmid (kindly provided by Drs. Joon Won Yoon and David Walterhouse, Children's Memorial Research Center, Northwestern University Feinberg School of Medicine, Chicago, IL). The pCMV-GLI(-)TAD was previously prepared by deleting a 1,409-bp AccI fragment from the 3' end of human GLI1 cDNA [16] . MC3T3 cells were transfected with 3 μg DNA using the Effectene reagent according to manufacturer's protocol (Qiagen), selected for stable transfection with G418 (Sigma), and cloned by limiting dilution (designated M-TAD cells). Parental MC3T3 and M-TAD cells were maintained at 37C, 5% CO 2 in nondifferentiation complete culture medium consisting of ascorbic acid (AA)-free α-MEM supplemented with 10% FBS, 100 U/ml penicillin and 100 μg/ml streptomycin (Gibco Invitrogen). 
Mixed Culture of Cells
RNA Isolation and Real Time Quantitative RT-PCR
Total RNA was extracted using Trizol (Invitrogen), purified using the RNeasy Mini Kit (Qiagen) and subjected to DNase treatment with RQ1 RNase-free DNase (Promega) to remove contaminating genomic DNA. The TaqMan ® Gold PCR Core Reagent Kit along with MuLV Reverse Transcriptase and RNase Inhibitor (Applied Biosystems) were used for cDNA synthesis. PCR primers (Invitrogen) and FAM-QSY7 probes (MegaBases, Inc.) for genes of interest and the housekeeping gene glyceraldehyde-3-phosphate dehydrogenase (Gapdh), whose sequences are shown in Table 1 , were designed using the Primer Express 3.0 software program. mRNA expression was measured in duplicate or triplicate per sample using 40 cycles of amplification in the 7500 Fast Real-Time PCR System (Applied Biosystems). Reactions were routinely performed without Reverse Transcriptase to demonstrate RNA dependence of the reaction products. Results were analyzed using the comparative C t method. C t is the threshold cycle at which the reporter fluorescence signal for each amplicon passes above a fixed baseline. The average C t of the gene of interest was normalized to that of the housekeeping gene Gapdh to obtain the ΔC t for that gene. ΔC t values between experimental and control samples were then compared (ΔΔC t ) to reflect the relative fold change in gene expression.
Cell Proliferation Assay
Cells were maintained as separate co-cultures as described above. MC3T3 cells were seeded onto 24-well tissue culture plates at 0.2 × 10 4 cells per well. Control LNCaP or LNShh cells were seeded at 2 × 10 4 cells per cell culture insert. Following overnight incubation, culture inserts were transferred to wells and co-cultures were maintained in AA-free α-MEM complete culture medium with media changes every 2-3 days. At specified times, cell inserts were removed and proliferation of MC3T3 cells grown on wells was determined using the Cell Counting Kit-8 (Dojindo Laboratories, Japan) which is based on the formation of a water-soluble formazan dye through the activity of dehydrogenases in living cells.
Immunocytochemistry and Immunofluorescence
Cells were maintained as mixed cultures in Lab-TekII CC2-treated chamber slides (Nunc) for the length of time specified in the experiments with media changes every 2-3 days. Cells were then fixed in 10% neutral buffered formalin for 10 minutes and permeated with 0.1% Triton X-100. For fluorescence immunocytochemistry, cells were stained with Alexa Flour 635 Phalloidin (Invitrogen: 1:40 dilution) and incubated in the dark for 20 minutes. Cells were counter-stained with 300 nM DAPI (Invitrogen). Slides were mounted using ProLong Gold antifade reagent (Invitrogen). For cytokeratin expression, fixed cells were stained with mouse monoclonal anti-human cytokeratin 8 antibody (DAKO: 1:50 dilution), developed with diaminobenzidine, and counterstained with hematoxylin. Slides were viewed in a Leica DMR-HC Upright Microscope and images were captured with imaging software (Improvision Openlab). Fluorescent images were captured at the following excitation/emission wavelengths (nm): Phalloidin-560/645; DAPI-360/470; GFP-480/527.
Alkaline Phosphatase Activity
Quantitative determination of ALP activity was done using the p-Nitrophenyl Phosphate (pNPP) Liquid Substrate System according to manufacturer's protocol (Sigma Aldrich). Briefly, cells in culture wells were treated with 0.2% Triton X-100, harvested with a cell scraper, and subjected to freeze-thaw cycles. Lysates were centrifuged and supernatants (10 μg protein) were incubated with 150 μl pNPP for 5 h at room temperature in the dark. Absorbance at 405 nm was measured using a microplate reader, and ALP activity was calculated according to manufacturer's instructions. Protein determination was done using the Bio-Rad DC Protein Microplate Assay according to manufacturer's protocol.
For ALP staining, mixed cultures were fixed with 10% neutral buffered formalin for 10 minutes and incubated with alkaline phosphatase substrate solution for at least 30 minutes at room temperature in the dark. The substrate solution was prepared by adding Naphthol AS-MX Phosphate Alkaline Solution to a diazonium salt solution (Fast Violet B Salt capsule dissolved in distilled water) just before use (Sigma-Aldrich).
Effect of Shh peptide
MC3T3 cells were seeded onto 6-well culture plates at 1 × 10 5 cells per well in AA-free α-MEM complete culture medium. Following overnight incubation, cells were treated with 1 μg/ml Shh-N, a modified active N-terminal peptide of human Shh (kindly provided by Curis Inc., Cambridge, MA), in serum-free AA-free α-MEM culture media for 24 h or 72 h.
Inhibition of Shh Signalling by Cyclopamine
Cultures of mixed cells (as described above) were maintained for 6 days in serum-free AA-free α-MEM culture medium with 1 or 10 μM cyclopamine (vehicle controls
